Apotex's Neulasta, Neupogen Biosimilars Clear Legal Hurdles, But Approval Questions Remain

 
• By Brenda Sandburg
Court of Appeals for Federal Circuit Lafayette Park Across from White House Washington DC
US Court of Appeals for the Federal Circuit rules in favor of Apotex on Amgen's infringement claims.

More from Biosimilars

More from Biosimilars & Generics